APA
Xu B., Feng Y., Cheng H., Song Y., Lv B., Wu Y., Wang C., Li S., Xu M., Du J., Peng K., Dong J., Zhang W., Zhang T., Zhu L., Ding H., Sheng Z., Welihinda A., Roberge J. Y., Seed B. & Chen Y. (20111122). C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. : Bioorganic & medicinal chemistry letters.
Chicago
Xu Baihua, Feng Yan, Cheng Huawei, Song Yanli, Lv Binhua, Wu Yuelin, Wang Congna, Li Shengbin, Xu Min, Du Jiyan, Peng Kun, Dong Jiajia, Zhang Wenbin, Zhang Ting, Zhu Liangcheng, Ding Haifeng, Sheng Zelin, Welihinda Ajith, Roberge Jacques Y, Seed Brian and Chen Yuanwei. 20111122. C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. : Bioorganic & medicinal chemistry letters.
Harvard
Xu B., Feng Y., Cheng H., Song Y., Lv B., Wu Y., Wang C., Li S., Xu M., Du J., Peng K., Dong J., Zhang W., Zhang T., Zhu L., Ding H., Sheng Z., Welihinda A., Roberge J. Y., Seed B. and Chen Y. (20111122). C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. : Bioorganic & medicinal chemistry letters.
MLA
Xu Baihua, Feng Yan, Cheng Huawei, Song Yanli, Lv Binhua, Wu Yuelin, Wang Congna, Li Shengbin, Xu Min, Du Jiyan, Peng Kun, Dong Jiajia, Zhang Wenbin, Zhang Ting, Zhu Liangcheng, Ding Haifeng, Sheng Zelin, Welihinda Ajith, Roberge Jacques Y, Seed Brian and Chen Yuanwei. C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. : Bioorganic & medicinal chemistry letters. 20111122.